| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/BI9703249 |
| P698 | PubMed publication ID | 9369482 |
| P2093 | author name string | D W Morris | |
| B Lin | |||
| J Y Chou | |||
| P433 | issue | 46 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glucose | Q37525 |
| Forkhead box A3 | Q21107409 | ||
| P304 | page(s) | 14096-106 | |
| P577 | publication date | 1997-11-18 | |
| P1433 | published in | Biochemistry | Q764876 |
| P1476 | title | The role of HNF1alpha, HNF3gamma, and cyclic AMP in glucose-6-phosphatase gene activation | |
| P478 | volume | 36 |
| Q48322350 | A combination of HNF-4 and Foxo1 is required for reciprocal transcriptional regulation of glucokinase and glucose-6-phosphatase genes in response to fasting and feeding |
| Q28511344 | A molecular link between the common phenotypes of type 1 glycogen storage disease and HNF1alpha-null mice |
| Q45876170 | AAV vector-mediated reversal of hypoglycemia in canine and murine glycogen storage disease type Ia. |
| Q47830802 | An alternative, human SRC promoter and its regulation by hepatic nuclear factor-1alpha. |
| Q30743983 | Application of experimentally verified transcription factor binding sites models for computational analysis of ChIP-Seq data |
| Q77110334 | Basal level glucose-6-phosphatase gene transcription requires binding sites for Sp family proteins within the gene promoter |
| Q33886919 | Cell-type specific expression of a dominant negative PKA mutation in mice |
| Q34646814 | Characterization of the human liver fructose-1,6-bisphosphatase gene promoter |
| Q33930092 | Complete normalization of hepatic G6PC deficiency in murine glycogen storage disease type Ia using gene therapy |
| Q44062730 | Cystathionine beta-synthase is coordinately regulated with proliferation through a redox-sensitive mechanism in cultured human cells and Saccharomyces cerevisiae |
| Q24793805 | Dietary effects of arachidonate-rich fungal oil and fish oil on murine hepatic and hippocampal gene expression |
| Q34666304 | Differential regulation of gene expression by insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR |
| Q39922682 | Differential regulation of the glucose-6-phosphatase TATA box by intestine-specific homeodomain proteins CDX1 and CDX2 |
| Q40886678 | Differential role of hepatocyte nuclear factor-1 in the regulation of glucose-6-phosphatase catalytic subunit gene transcription by cAMP in liver- and kidney-derived cell lines |
| Q38320716 | Distinct mechanisms of glucose lowering by specific agonists for peroxisomal proliferator activated receptor gamma and retinoic acid X receptors |
| Q33966276 | Elevated levels of hepatocyte nuclear factor 3beta in mouse hepatocytes influence expression of genes involved in bile acid and glucose homeostasis |
| Q28566783 | Fatty acids-stress attenuates gluconeogenesis induction and glucose production in primary hepatocytes |
| Q34288965 | GATA-4, GATA-5, and GATA-6 activate the rat liver fatty acid binding protein gene in concert with HNF-1alpha. |
| Q36789527 | Gene therapy for type I glycogen storage diseases |
| Q36478114 | Genome-wide analysis of FoxO1 binding in hepatic chromatin: potential involvement of FoxO1 in linking retinoid signaling to hepatic gluconeogenesis |
| Q92374184 | Glucose metabolism is differentially altered by choline and methionine in bovine neonatal hepatocytes |
| Q28513198 | Hepatocyte nuclear factor-1 acts as an accessory factor to enhance the inhibitory action of insulin on mouse glucose-6-phosphatase gene transcription |
| Q35568513 | Hepatorenal correction in murine glycogen storage disease type I with a double-stranded adeno-associated virus vector |
| Q40106533 | Human nuclear pregnane X receptor cross-talk with CREB to repress cAMP activation of the glucose-6-phosphatase gene. |
| Q38328020 | Identification of a cAMP response element within the glucose- 6-phosphatase hydrolytic subunit gene promoter which is involved in the transcriptional regulation by cAMP and glucocorticoids in H4IIE hepatoma cells |
| Q45876893 | In search of proof-of-concept: gene therapy for glycogen storage disease type Ia. |
| Q34089344 | Insulin and epidermal growth factor suppress basal glucose-6-phosphatase catalytic subunit gene transcription through overlapping but distinct mechanisms |
| Q34727273 | Integrative genomic analysis of CREB defines a critical role for transcription factor networks in mediating the fed/fasted switch in liver |
| Q39457251 | Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury |
| Q80991756 | Lack of significant long-term effect of dietary carbohydrates on hepatic glucose-6-phosphatase expression in rainbow trout (Oncorhynchus mykiss) |
| Q33588394 | Microsomal and Cytosolic Scaling Factors in Dog and Human Kidney Cortex and Application for In Vitro-In Vivo Extrapolation of Renal Metabolic Clearance |
| Q77735599 | Molecular Genetics of Type 1 Glycogen Storage Diseases |
| Q33860346 | New lessons in the regulation of glucose metabolism taught by the glucose 6-phosphatase system |
| Q38067621 | Primary hepatocyte cultures for pharmaco-toxicological studies: at the busy crossroad of various anti-dedifferentiation strategies |
| Q40816184 | Protein kinase A phosphorylates hepatocyte nuclear factor-6 and stimulates glucose-6-phosphatase catalytic subunit gene transcription |
| Q34920348 | Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis |
| Q41810904 | STAT3 targets the regulatory regions of gluconeogenic genes in vivo |
| Q44726977 | Selective stimulation of G-6-Pase catalytic subunit but not G-6-P transporter gene expression by glucagon in vivo and cAMP in situ |
| Q43733891 | Selective tonic inhibition of G-6-Pase catalytic subunit, but not G-6-P transporter, gene expression by insulin in vivo |
| Q34766859 | Suppression of gluconeogenic gene expression by LSD1-mediated histone demethylation |
| Q24670887 | The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression |
| Q21144913 | The histone demethylase Jhdm1a regulates hepatic gluconeogenesis |
| Q38312515 | The molecular physiology of hepatic nuclear factor 3 in the regulation of gluconeogenesis |
| Q40208423 | The promoter for the gene encoding the catalytic subunit of rat glucose-6-phosphatase contains two distinct glucose-responsive regions |
| Q28565514 | Transcriptional regulation of the glucose-6-phosphatase gene by cAMP/vasoactive intestinal peptide in the intestine. Role of HNF4alpha, CREM, HNF1alpha, and C/EBPalpha |
| Q24800260 | cAMP response element binding protein (CREB) activates transcription via two distinct genetic elements of the human glucose-6-phosphatase gene |
| Q40363311 | rAAV9 combined with renal vein injection is optimal for kidney-targeted gene delivery: conclusion of a comparative study |
Search more.